Pay in 4 interest-free payments of $6.13 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Retatrutide has produced the largest weight loss reported in any Phase 3 obesity trial so far, but a UK launch is at least 18 months away
Yes, through four paths: NovoCare self-pay (Wegovy $199 intro/$349, Ozempic $349 to $499)
Book a medical weight loss consultation with us today and take the first step toward a healthier, more confident you
Do not combine retatrutide with semaglutide, tirzepatide, or any other GLP-1 receptor agonist
Given where the regulatory landscape stands as of May 2026, it deserves direct treatment - because it affects every compounded GLP-1 platform currently operating, and the timeline for resolution is not yet settled
The actual duty amount depends on the HS code classification of the specific product
US$ 29.39
US$ 22.61
US$ 21.02
US$ 28.63
US$ 22.70
US$ 27.12
